Cargando…

Expression of EZH2 is associated with poor outcome in colorectal cancer

Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein family, has been demonstrated to be overexpressed in various types of human cancer, including hepatocellular carcinoma, breast, bladder and lung cancer. The mechanism of how EZH2 promotes oncogenesis has also been w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhuanpeng, Yang, Ping, Li, Wanglin, He, Feng, Wei, Jianchang, Zhang, Tong, Zhong, Junbin, Chen, Huacui, Cao, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778885/ https://www.ncbi.nlm.nih.gov/pubmed/29435024 http://dx.doi.org/10.3892/ol.2017.7647

Ejemplares similares

Overexpression of transcription factor activating enhancer binding protein 4 (TFAP4) predicts poor prognosis for colorectal cancer patients
por: Wei, Jianchang, et al.
Publicado: (2017)

Establishment of multiple diagnosis models for colorectal cancer with artificial neural networks
por: Wang, Qiang, et al.
Publicado: (2019)

Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression
por: He, Feng, et al.
Publicado: (2016)

Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance
por: Cao, Jie, et al.
Publicado: (2018)

Long noncoding RNA PVT1-214 promotes proliferation and invasion of colorectal cancer by stabilizing Lin28 and interacting with miR-128
por: He, Feng, et al.
Publicado: (2018)

Survival outcome of local vs. radical excision in rectal gastrointestinal stromal tumor: a SEER database analysis
por: Wei, Jianchang, et al.
Publicado: (2022)

A survival comparison of gastric mucin-producing adenocarcinoma to conventional adenocarcinoma: a SEER database analysis
por: Wang, Qiang, et al.
Publicado: (2021)

Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels
por: Wang, Qiang, et al.
Publicado: (2018)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression
por: Yang, Liu, et al.
Publicado: (2021)

LINC00565 promotes the progression of colorectal cancer by upregulating EZH2
por: Shao, Xiaxia, et al.
Publicado: (2021)

Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms
por: Zhang, Qi, et al.
Publicado: (2019)

High expression of GPR116 indicates poor survival outcome and promotes tumor progression in colorectal carcinoma
por: Yang, Li, et al.
Publicado: (2017)

Silencing of MBD2 and EZH2 inhibits the proliferation of colorectal carcinoma cells by rescuing the expression of SFRP
por: Xie, Yang, et al.
Publicado: (2021)

EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
por: Lin, Zhuangling, et al.
Publicado: (2023)

High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
por: Chen, Zhitao, et al.
Publicado: (2022)

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis
por: Fluge, Ø, et al.
Publicado: (2009)

Dysregulated Expression of Long Non-Coding RNA MINCR and EZH2 in Colorectal Cancer
por: Cheraghi, Sajjad, et al.
Publicado: (2022)

Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
por: Changchien, Yi-Che, et al.
Publicado: (2012)

NBPF4 mitigates progression in colorectal cancer through the regulation of EZH2‐associated ETFA
por: Chen, Wankun, et al.
Publicado: (2021)

High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas
por: Wong, Yin Ping, et al.
Publicado: (2022)

RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2020)

Retraction Note: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer
por: Tan, Xiao, et al.
Publicado: (2023)

High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer
por: Jang, Si-Hyong, et al.
Publicado: (2016)

EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis
por: Sun, Chenmin, et al.
Publicado: (2018)

Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression
por: Yu, Junhui, et al.
Publicado: (2022)

Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma
por: Hu, Liang, et al.
Publicado: (2015)

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
por: Schümann, Franziska Lea, et al.
Publicado: (2021)

Unveiling the non-canonical functions of EZH2 in prostate cancer
por: Yi, Yang, et al.
Publicado: (2023)

EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment
por: Li, Chen, et al.
Publicado: (2022)

Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer
por: Chen, Zhihui, et al.
Publicado: (2019)

Increased LEF1 Expression and Decreased Notch2 Expression Are Strong Predictors of Poor Outcomes in Colorectal Cancer Patients
por: Wang, Wen-Juan, et al.
Publicado: (2013)

Correction: Activation of FXR and inhibition of EZH2 synergistically inhibit colorectal cancer through cooperatively accelerating FXR nuclear location and upregulating CDX2 expression
por: Yu, Junhui, et al.
Publicado: (2023)

HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer
por: Chen, Wen-Ming, et al.
Publicado: (2017)

LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2
por: Lu, Wei, et al.
Publicado: (2021)

Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands
por: Zhong, Jian, et al.
Publicado: (2022)

Prognostic and biological function value of OSBPL3 in colorectal cancer analyzed by multi-omic data analysis
por: Wang, Chengxing, et al.
Publicado: (2023)

EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics
por: Yamamoto, Itaru, et al.
Publicado: (2017)

Yes-associated protein expression is associated with poor prognosis in patients with colorectal cancer
por: Cao, Liyu, et al.
Publicado: (2021)

The role of EZH1 and EZH2 in development and cancer
por: Lee, Soo Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_35ro2hg8rkkf4r1568ncacuq1a